Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Cystic fibrosis Stories

2012-06-12 02:26:23

AUSTIN, Texas, June 12, 2012 /PRNewswire/ -- Savara Pharmaceuticals, an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions, today announced positive top-line data from its AeroVanc Phase I clinical study in patients with cystic fibrosis (CF). AeroVanc, a dry powder formulation of vancomycin, is the first inhaled antibiotic being developed for the treatment of respiratory methicillin-resistant...

2012-06-12 02:26:22

AUSTIN, Texas, June 12, 2012 /PRNewswire/ -- Savara Pharmaceuticals, an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions, today announced that it has raised $8.6 million in the first closing of a Series B round of financing. The Keiretsu Forum, comprising accredited private equity investors, led the financing with participation from Savara's existing investors. Savara will use the proceeds from this...

2012-06-08 06:26:18

SOUTH PLAINFIELD, N.J., June 8, 2012 /PRNewswire/ -- PTC Therapeutics, Inc. today announced the results from a Phase 3 study of ataluren, an investigational new drug, in patients with nonsense mutation cystic fibrosis (nmCF). The results demonstrated positive trends in lung function as measured by FEV1 (forced expiratory volume in one second) and in the secondary outcome measure, rate of pulmonary exacerbations. Results also showed a substantial ataluren treatment effect in FEV1 and...

2012-06-06 06:20:16

World-renowned Dirty Car Artist Scott Wade joins ninth annual Soaps It Up for Cystic Fibrosis Canada HAMILTON, ON, June 6, 2012 /CNW/ - For the past eight years, dirty cars have been making beautiful things happen for Cystic Fibrosis Canada through the annual CARSTAR Soaps It Up for Cystic Fibrosis National Car Wash Fundraiser. At this year's event on Saturday, June 9th, CARSTAR locations across the country will surpass $2-million in funds raised for Cystic Fibrosis Canada.  To...

2012-05-30 02:25:31

MONMOUTH JUNCTION, N.J., May 30, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today provided a corporate update, including the Company's current strategic development priorities for ARIKACE® (liposomal amikacin for inhalation). "Insmed has determined that its current resources will be applied towards the CLEAR-108 phase 3 European and Canadian registrational study of ARIKACE in patients with Cystic Fibrosis (CF)-related Pseudomonas aeruginosa...

2012-05-29 23:02:55

Award-winning healthcare communications agency bryantBROWN launches innovative Spiro PD Personal Spirometer for PMD Healthcare. Campaign targets people with asthma, COPD, cystic fibrosis, and lung transplants, plus their healthcare professionals. Contact bryantBROWN at http://www.bryantbrown.com for more information. Los Angeles, CA (PRWEB) May 29, 2012 The award-winning healthcare communications agency bryantBROWN Healthcare has created the launch campaign for the innovative, new Spiro PD,...

2012-05-29 02:27:36

WOONSOCKET, R.I., May 29, 2012 /PRNewswire/ -- On May 27, CVS/pharmacy launched a new in-store fundraising campaign named Advancing Medical Research, to support medical research and help improve the quality of life for those living with amyotrophic lateral sclerosis (ALS) and cystic fibrosis (CF). Funds raised through the campaign will benefit the ALS Therapy Alliance (ATA), a leading organization dedicated to advancing ALS research, and the Cystic Fibrosis Foundation, the world's leader in...

2012-05-23 20:09:40

Patients with chronic obstructive pulmonary disease (COPD) who become infected with the bacterium Pseudomonas aerguinosa are more likely to have worse clinical outcomes and experience more hospitalizations during the course of their disease than COPD patients who are not infected, according to researchers from Buffalo, N.Y. The study will be presented at the ATS 2012 International Conference in San Francisco. Bacterial bronchial infection plays a key role in the course of COPD, causing...

2012-05-21 12:46:36

Margaret Rosenfeld, M.D., M.P.H., of Seattle Children's Hospital, and colleagues conducted a study to examine if hypertonic saline would reduce the rate of pulmonary exacerbations in children younger than 6 years of age with cystic fibrosis (CF). Inhaled hypertonic saline is recommended as therapy for patients 6 years or older with CF, but its efficacy has not been evaluated in patients younger than 6 years. In the randomized trial, the active treatment group (n = 158) received 7 percent...

2012-05-17 06:25:04

Tens of Thousands Join Effort to Find a Cure During Cystic Fibrosis Awareness Month BETHESDA, Md., May 17, 2012 /PRNewswire-USNewswire/ -- Tens of thousands of people in more than 200 cities will participate in Great Strides walks May 19-20, 2012, to raise critical funds for cystic fibrosis research, education and care, the Cystic Fibrosis Foundation announced today. Great Strides is the largest national fundraiser for cystic fibrosis, a fatal genetic disease that causes debilitating...


Latest Cystic fibrosis Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »